BRWJX
Price
$28.29
Change
+$0.27 (+0.96%)
Updated
Sep 4 closing price
Net Assets
451.45M
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

BRWJX vs RGEBX

Header iconBRWJX vs RGEBX Comparison
Open Charts BRWJX vs RGEBXBanner chart's image
MFS Blended Research Growth Eq I
Price$28.29
Change+$0.27 (+0.96%)
VolumeN/A
Net Assets451.45M
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
BRWJX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRWJX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRWJX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. BRWJX (451M). BRWJX pays higher dividends than RGEBX: BRWJX (0.32) vs RGEBX (0.00). BRWJX was incepted earlier than RGEBX: BRWJX (10 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than BRWJX (0.60). BRWJX is a more actively managed with annual turnover of: 46.00 vs. RGEBX (25.00). BRWJX has a lower initial minimum investment than RGEBX: BRWJX (0) vs RGEBX (250). BRWJX annual gain was more profitable for investors over the last year : 22.66 vs. RGEBX (17.59). BRWJX return over 5 years is better than : 57.71 vs. RGEBX (38.71).
BRWJXRGEBXBRWJX / RGEBX
Total Expense Ratio0.491.0945%
Annual Report Gross Expense Ratio0.601.0955%
Fund Existence10 years11 years-
Gain YTD12.28115.39880%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets451M332B0%
Annual Yield % from dividends0.320.00-
Returns for 1 year22.6617.59129%
Returns for 3 years84.7357.61147%
Returns for 5 years57.7138.71149%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd